Zahra Hashemi

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Bone marrow transplants (BMTs) are mainly limited by a low number of CD34+ cells. The transforming growth factor-beta (TGF-β) pathway downregulation is a key factor that increases cell self-renewal. In nature, hematopoietic stem cells (HSCs) are in a microenvironment, surrounded by cells in a three-dimensional (3D) configuration. The aim of this study is to(More)
OBJECTIVE(S) Ex vivo expansion of hematopoitic stem cells is an alternative way to increase umbilical cord blood (UCB)-CD34+ cells for bone marrow transplantation. For this purpose demineralized bone matrix (DBM) and mineralized bone allograft (MBA) as two scaffolds based on bone matrix and stem cell niche, were simultaneously used to enhance the effect of(More)
  • 1